의료용 로봇 시장 : 제품 유형별, 기술별, 용도별, 최종 사용자별 시장 예측(2026-2032년)

The Healthcare Robotics Market is projected to grow by USD 33.73 billion at a CAGR of 9.98% by 2032.

Healthcare Robotics Introduction for Providers

Healthcare robotics has moved from a narrow surgical automation category to a connected clinical operations market spanning robot-assisted surgery, rehabilitation robotics, hospital logistics, pharmacy automation, telepresence, disinfection, and assistive care. Adoption is supported by measurable pressure on health systems: the World Health Organization projects a global shortage of 10 million health workers by 2030, while United Nations data confirms rapid population aging is increasing demand for surgery, chronic disease management, rehabilitation, and long-term care.

For providers, the executive priority is not simply buying robots; it is integrating medical robotics into evidence-based workflows that improve throughput, safety, precision, and workforce productivity. The strongest healthcare robotics strategies align capital planning, clinical governance, cybersecurity, AI validation, reimbursement readiness, and staff training with measurable outcomes such as operating room utilization, infection prevention, patient mobility, medication safety, and length-of-stay reduction.

Transformative Shifts in Healthcare Robotics

The healthcare robotics landscape is being reshaped by three verified forces: workforce shortages, value-based care, and rising procedural complexity. Hospitals are using surgical robots to support minimally invasive procedures, logistics robots to reduce non-clinical labor burdens, and rehabilitation robots to standardize high-intensity therapy. These shifts are especially relevant as health systems seek better asset utilization and more consistent quality across sites of care.

Technology convergence is also transforming purchasing criteria. Robotics platforms increasingly combine sensors, imaging, navigation, connectivity, and software analytics. As a result, providers are evaluating total cost of ownership, interoperability with electronic health records and imaging systems, clinical training requirements, regulatory clearance, service uptime, cybersecurity, and measurable workflow impact rather than hardware alone.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating healthcare robotics by improving perception, navigation, workflow automation, and decision support. In surgical robotics, AI-enabled image analysis and procedural analytics can help standardize training and identify performance variation. In hospital automation, machine learning supports route optimization, inventory prediction, and task scheduling for autonomous mobile robots.

The cumulative impact of AI is strongest when robotics is deployed with strict clinical governance. Providers must validate models, monitor drift, protect patient data under HIPAA, GDPR, and comparable privacy regimes, and maintain human oversight for clinical decisions. AI-powered medical robotics can increase consistency and operational resilience, but safe adoption depends on transparent algorithms, auditable performance metrics, explainable risk controls, and multidisciplinary review.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific is a major growth engine for healthcare robotics due to rapid hospital modernization, aging demographics in Japan, South Korea, and China, expanding medical device manufacturing capacity, and public investment in digital health infrastructure. North America remains a leading adoption hub because of advanced hospital capital budgets, FDA-regulated medical device pathways, strong clinical research ecosystems, high procedure volumes, and demand for minimally invasive surgery, pharmacy automation, rehabilitation robotics, and hospital logistics automation.

Europe shows steady demand supported by universal healthcare systems, medical technology clusters, and strong regulatory discipline under the EU Medical Device Regulation, with privacy governance reinforced by GDPR. Latin America is adopting robotics selectively in large private hospitals, academic centers, and specialty care networks, particularly where high-complexity surgery and rehabilitation services are concentrated. The Middle East is investing in smart hospitals, digital transformation, and medical tourism, particularly across Gulf health systems. Africa remains earlier in adoption, with practical opportunities tied to telepresence, clinician training, remote care, rehabilitation access, and scalable automation that addresses specialist and infrastructure gaps.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN healthcare robotics demand is being shaped by private hospital networks, medical tourism, and government-backed digital health strategies in markets such as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, where care-quality differentiation and specialist access are key priorities. The GCC is advancing robotics through high-capacity hospital investments, national health transformation programs, medical tourism strategies, and demand for premium surgical, rehabilitation, and smart hospital services.

The European Union provides a structured regulatory and procurement environment for robotics adoption, with emphasis on medical device safety, clinical evidence, cybersecurity, and data protection. BRICS countries offer scale, domestic manufacturing potential, and healthcare access expansion, led by China and India in robotics innovation, digital health deployment, and capacity building. G7 markets represent mature demand for surgical robotics, automation, and assistive care, supported by advanced reimbursement, research, and hospital infrastructure. NATO countries increasingly view resilient healthcare infrastructure, cybersecurity, emergency preparedness, and medtech supply chains as strategic priorities, strengthening the relevance of secure and interoperable healthcare robotics.

Key Country Insights in Healthcare Robotics

The United States leads in surgical robotics adoption, clinical innovation, venture investment, and FDA-cleared robotic systems, while Canada emphasizes evidence-based procurement, health technology assessment, and equitable access across provincial health systems. Mexico and Brazil are expanding use in private hospitals and high-complexity centers, with demand linked to specialty surgery, rehabilitation, pharmacy automation, and hospital efficiency.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show strong interest in robot-assisted surgery, rehabilitation, assistive care, and hospital automation, while Germany benefits from deep engineering, industrial automation, and medical technology manufacturing capabilities. France and the United Kingdom emphasize clinical evaluation, procurement discipline, and digital health integration; Italy and Spain show demand in surgical excellence centers and rehabilitation networks. Russia maintains selected robotics activity in research, engineering, and tertiary care despite procurement and supply-chain constraints. In Asia-Pacific, China is scaling domestic robotics production and hospital adoption, India is expanding access through private healthcare networks and specialty hospitals, Japan and South Korea are leaders in aging-care robotics, rehabilitation technologies, and precision manufacturing, and Australia uses robotics to support specialist care quality, surgical access, rehabilitation services, and care delivery across geographically dispersed populations.

Actionable Recommendations for Healthcare Leaders

Industry leaders should build robotics roadmaps around clinical value, not technology novelty. Priority actions include selecting use cases with measurable outcomes, creating multidisciplinary governance committees, standardizing training and credentialing, and requiring technology partners to provide uptime, cybersecurity, interoperability, service support, and post-market evidence commitments.

Providers should also plan for AI readiness by establishing data governance, model monitoring, workflow redesign, privacy safeguards, and human oversight before deployment. The most successful organizations will combine robotics with workforce strategy, digital infrastructure, reimbursement planning, and patient experience goals, ensuring that automation improves clinical capacity rather than adding operational complexity.

Research Methodology

This executive summary is grounded in secondary research from public regulatory databases, health authority guidance, peer-reviewed medical literature, government healthcare strategies, public health datasets, standards bodies, and recognized international organizations including the World Health Organization, OECD, United Nations, and regional regulatory bodies. Market interpretation emphasizes verified adoption drivers, technology capabilities, healthcare system constraints, and regulatory considerations without relying on market sizing or forecasting.

The analysis uses triangulation across clinical, operational, regulatory, and geographic indicators. Insights were evaluated for relevance to healthcare robotics use cases, including surgical robotics, rehabilitation robotics, telepresence systems, hospital logistics robots, pharmacy automation, disinfection robots, and assistive care systems, with emphasis on data-backed workforce, demographic, safety, and digital health trends.

Conclusion: Robotics as a Strategic Healthcare Infrastructure Layer

Healthcare robotics is becoming a strategic infrastructure layer for modern healthcare delivery. It supports precision, consistency, staff productivity, infection prevention, rehabilitation intensity, medication safety, and access to care at a time when hospitals face labor shortages, aging populations, and pressure to improve outcomes.

Organizations that pair robotics with AI governance, clinical evidence, secure integration, and workforce enablement will be best positioned to capture long-term value. The industry outlook favors leaders that treat medical robotics as an enterprise transformation program rather than a standalone equipment purchase.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Healthcare Robotics Market, by Product Type

• 7.1. Diagnostic & Imaging Robots
• 7.2. Noninvasive-Radiosurgery Robotic Systems
• 7.3. Pharmacy & Laboratory Robotics
• 7.4. Rehabilitation Robotic Systems
  • 7.4.1. Assistive Robotic Systems
  • 7.4.2. Exoskeleton Robotic Systems
  • 7.4.3. Therapeutic Robotic Systems
• 7.5. Service & Logistics Robots
• 7.6. Surgical Robots

8. Healthcare Robotics Market, by Technology

• 8.1. Artificial Intelligence
• 8.2. Augmented Reality
  • 8.2.1. Patient Engagement AR
  • 8.2.2. Surgical Training AR
• 8.3. Internet of Things (IoT)
• 8.4. Machine Learning

9. Healthcare Robotics Market, by Application

• 9.1. Cardiology
• 9.2. Laparoscopy
• 9.3. Neurology
• 9.4. Orthopedics

10. Healthcare Robotics Market, by End-User

• 10.1. Hospitals & Clinics
• 10.2. Rehabilitation Centers
• 10.3. Surgical Centers
  • 10.3.1. Ambulatory Surgery Centers
  • 10.3.2. Day Surgery Centers

11. Healthcare Robotics Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Healthcare Robotics Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Healthcare Robotics Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Concentration Analysis, 2025
  • 14.1.1. Concentration Ratio (CR)
  • 14.1.2. Herfindahl Hirschman Index (HHI)
• 14.2. Recent Developments & Impact Analysis, 2025
• 14.3. Product Portfolio Analysis, 2025
• 14.4. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. ANGEL ROBOTICS CO., LTD.
• 15.2. Astrek Innovations
• 15.3. B-Temia Inc.
• 15.4. Bionik Laboratories Corp.
• 15.5. Bioservo AB
• 15.6. Blatchford Group Ltd.
• 15.7. CYBERDYNE, INC.
• 15.8. Ekso Bionics Holdings, Inc.
• 15.9. Embla Medical
• 15.10. Exoatlet Global S.A.
• 15.11. Fillauer, Inc.
• 15.12. German Bionic Systems GmbH
• 15.13. GOGOA MOBILITY ROBOTS, S.L.
• 15.14. Hanger, Inc.
• 15.15. Hocoma AG by DIH Technology d.o.o.
• 15.16. Honda Motor Co., Ltd.
• 15.17. Hyundai Motor Company
• 15.18. Lifeward, Ltd.
• 15.19. Limb Lab, LLC
• 15.20. MARSI BIONICS, S.L.
• 15.21. Motus Nova
• 15.22. Myomo Inc.
• 15.23. NEOFECT
• 15.24. OTTOBOCK SE & CO. KGaA
• 15.25. Rehab-Robotics Company Limited
• 15.26. Rex Bionics Ltd.
• 15.27. Samsung Electronics Co., Ltd.
• 15.28. Shanghai Fourier Intelligent Technology Co., Ltd.
• 15.29. Technaid S.L.
• 15.30. Wandercraft SAS
• 15.31. Wearable Robotics
• 15.32. WIRobotics Inc.